Ismail Jatoi

Follow

Generating author description...

Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ A parametric model for long‐term follow‐up data from phase III breast cancer clinical trials 2003 Jong‐Hyeon Jeong
Sin‐Ho Jung
Samuel Wieand
2
+ Nonparametric Estimation from Incomplete Observations 1992 Edward L. Kaplan
Paul Meier
2
+ Frailty models and rank tests. 1998 David Oakes
Jong‐Hyeon Jeong
1
+ Estimation of failure probabilities in the presence of competing risks: new representations of old estimators 1999 Ted Gooley
Wendy M. Leisenring
John Crowley
Barry E. Storer
1
+ An Introduction to the Bootstrap 1994 Bradley Efron
Robert Tibshirani
1
+ Approaches to monitoring the results of long-term disease prevention trials: Examples from the Women's Health Initiative 1996 Laurence S. Freedman
Garnet L. Anderson
Victor Kipnis
Ross L. Prentice
C.Y. Wang
Jacques E. Rossouw
Janet Wittes
David L. DeMets
1
+ “Proving the null hypothesis” in clinical trials 1982 William C. Blackwelder
1
+ Statistical Power for a Long-Term Survival Trial with a Time-Dependent Treatment Effect 2000 Jiandong Lu
Thomas F. Pajak
1
+ Hazard Function Estimation Using B-Splines 1995 Philip S. Rosenberg
1
+ A class of rank test procedures for censored survival data 1982 David P. Harrington
Thomas R. Fleming
1
+ Information Theory and an Extension of the Maximum Likelihood Principle 1998 H. Akaike
1
+ Analysis and Interpretation of Treatment Effects in Subgroups of Patients in Randomized Clinical Trials 1991 Salim Yusuf
Janet Wittes
Jeffrey L. Probstfield
Herman A. Tyroler
1
+ TIME-DEPENDENT COVARIATES IN THE COX PROPORTIONAL-HAZARDS REGRESSION MODEL 1999 Lloyd D. Fisher
D. Y. Lin
1
+ Subgroup analysis and other (mis)uses of baseline data in clinical trials 2000 Susan F. Assmann
Stuart J. Pocock
Laura E. Enos
Linda Kasten
1
+ PDF Chat The number needed to treat: a clinically useful measure of treatment effect 1995 Richard J. Cook
D L Sackett
1
+ Commentary: The Hazards of Survival Comparisons 2007 Donald A. Berry
1
+ Hazard function estimators: a simulation study 1999 Kenneth R. Hess
Dan M. Serachitopol
Barry W. Brown
1
+ PDF Chat Through the looking glass: understanding non-inferiority 2011 Jennifer Schumi
Janet Wittes
1
+ Dose‐Finding Based on Efficacy–Toxicity Trade‐Offs 2004 Peter F. Thall
John D. Cook
1
+ Study control, violators, inclusion criteria and defining explanatory and pragmatic trials 2002 Alex D. McMahon
1
+ PDF Chat An approach to trial design and analysis in the era of non-proportional hazards of the treatment effect 2014 Patrick Royston
Mahesh Parmar
1
+ Subgroup analysis in randomised controlled trials: importance, indications, and interpretation 2005 Peter M. Rothwell
1
+ A comparison of sample size methods for the logrank statistic 1992 Edward Lakatos
K. K. Gordon Lan
1
+ PDF Chat Randomized Clinical Trial Design for Assessing Noninferiority When Superiority Is Expected 2007 Boris Freidlin
Edward L. Korn
Stephen L. George
Robert J. Gray
1
+ Approaches in modelling long‐term survival: an application to breast cancer 2006 Aris Perperoglou
A. Keramopoullos
Hans C. van Houwelingen
1
+ PDF Chat Survival Analysis Techniques for Censored and Truncated Data 1998 Marepalli B. Rao
John P. Klein
Melvin L. Moeschberger
1
+ AN EMPIRICAL COMPARISON OF STATISTICAL TESTS FOR ASSESSING THE PROPORTIONAL HAZARDS ASSUMPTION OF COX'S MODEL 1997 Nicholas NgĘźandu
1
+ PDF Chat Breast Cancer Adjuvant Therapy: Time to Consider Its Time-Dependent Effects 2011 Ismail Jatoi
William F. Anderson
Jong‐Hyeon Jeong
Carol Redmond
1
+ The Cox Proportional Hazards Model with Change Point: An Epidemiologic Application 1990 Kung‐Yee Liang
Steven G. Self
Xinhua Liu
1
+ PDF Chat Using Outcomes to Analyze Patients Rather than Patients to Analyze Outcomes: A Step Toward Pragmatism in Benefit:Risk Evaluation 2016 Scott Evans
Dean Follmann
1
+ PDF Chat Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic review 2017 Turki A. Althunian
Anthonius de Boer
Olaf H. Klungel
Widya N. Insani
Rolf H. H. Groenwold
1
+ PDF Chat Challenges in the Design and Interpretation of Noninferiority Trials 2017 Laura Mauri
Ralph B. D’Agostino
1
+ Regression Models and Non-Proportional Hazards in the Analysis of Breast Cancer Survival 1984 Sheila M. Gore
Stuart J. Pocock
G.R. Kerr
1
+ Nonparametric Estimation from Incomplete Observations 1958 Edward L. Kaplan
Paul Meier
1
+ Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials 1991 S. Yusuf
1
+ Clinical Trials— <scp>II</scp> 2005 Richard Simon
1
+ Nonparametric Estimation from Incomplete Observations 1958 Edward L. Kaplan
Paul Meier
1
+ Modeling Survival Data: Extending the Cox Model 2000 Terry M. Therneau
Patricia M. Grambsch
1